Company Profile of HYBIO PHARMACEUTICAL CO., LTD

Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, after over decades of effort, we have grown to be one of the largest and most professional peptide pharmaceutical company in China. We were one of the first to enter the peptide pharmaceutical industry in China, and we are the first peptide public company in China. Hybio has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CDMO&CMO services. Our peptide finished dosage is mainly sold in the domestic market, and some of our peptide APIs have been supplied to customers all over the world. Hybio is a GMP-approved pharmaceutical company, we have strong quality management system and our facilities have been approved by USFDA, EU, KFDA, ANVISA and other Countries' authorities.